Zeynep Güneş Tepe Demir

Mrs. Zeynep Güneş Tepe Demir

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2022 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
Zeynep Güneş Tepe DemirZeynep Güneş Tepe Demir
Zeynep Güneş Tepe Demir
YYYılmaz Yücehan Yazıcı
Yılmaz Yücehan Yazıcı
UTUmut Tank
Umut Tank
LKLadin Işık Köse
Ladin Işık Köse
MÖMurat Özer
Murat Özer
SBSerkan Belkaya
Serkan Belkaya

7 January 2025 in STAR Protocols
Verified
Journal Article
Open access
VLVictor H.K. Lam
Victor H.K. Lam
AGAleena Ghafoor
Aleena Ghafoor
YKYazan Khan
Yazan Khan
SCShirley Constable
Shirley Constable
LBLane B. Buchanan
Lane B. Buchanan
JPJessica Lynn Prodger
Jessica Lynn Prodger
Air-liquid interface (ALI) culture can differentiate airway epithelial cells to recapitulate the respiratory tract in vitro. Here, we present a protocol for isolating and culturing nasal epithelial cells from turbinate tissues for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We describe steps to overcome challenges of imaging fragile cultures, detect the production of mucus, and quantify intracellular virus post-SARS-CoV-2 infection. We present data on the optimal duration of ALI maturation prior to experimentation and describe which steps can be altered to optimize testing of specific hypotheses.

28 May 2026 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
CCCan Cetin
Can Cetin
Onur Cem NamliOnur Cem Namli
Onur Cem Namli
GDGulengul Duman
Gulengul Duman
Zeynep Güneş Tepe DemirZeynep Güneş Tepe Demir
Zeynep Güneş Tepe Demir
OKOkan Kuzhan
Okan Kuzhan

1 January 2024 in Journal of Research in Pharmacy
Verified
Journal Article
Open access
PDF file
GDGulengul Duman
Gulengul Duman
Zeynep Güneş Tepe DemirZeynep Güneş Tepe Demir
Zeynep Güneş Tepe Demir
FKFatih Kocabaş
Fatih Kocabaş
BGBirkan Gi̇rGi̇n
Birkan Gi̇rGi̇n
Lactoferrin is a potential anticancer protein naturally found in mammalian secretions. It shows antiproliferative effects on various cancer types in vitro and in vivo. Its activity is highly associated with the immune system and its complements. On the other hand, hyperthermia is a type of cancer therapy in which tissues are exposed to heat at a temperature in the range of 40ºC-44ºC which induces apoptosis and necrosis. Hyperthermia normally aims to improve the results of conventional treatment strategies such as chemo or radiotherapy. The study aimed to enhance the lactoferrin effect with hyperthermia. Hyaluronic acid was additionally used in the formulation to augment the anticancer effect of lactoferrin. MTT Assays were performed for cell viability at 24 and 72 hours after the lactoferrin, hyaluronic acid, and hyperthermia treatment on MCF-7, MDA-MB 231, and HDF cell lines in vitro. No anticancer efficacy of lactoferrin was observed. However, it was demonstrated that Hyaluronic acid enhanced the anti-proliferative efficacy of hyperthermia treatment, and significant reductions in the cell viability were observed after 24 hours on MCF-7 cells in a p53-dependent manner whereas no reduction in the cell viability of MDAMB 231 and HDF cells. Mutation on the p53 gene of MDA-MB 231 cells possibly prevented the heat-induced apoptosis. Hyaluronic acid-induced cell death was observed 72 hours after the treatment independently from the heat exposure group. No cytotoxicity was observed on the HDF cell line. The activity could not be obtained from the pure hyaluronic acid solution. Subsequent determination of the chemical responsible for the anticancer efficacy should be performed. This research could lead to the discovery of a new selective chemotherapeutic agent that can be used in breast cancer.

30 August 2025 in Separations
Verified
Journal Article
Open access
PDF file
MSMarion Sicot
Marion Sicot
CGClaire Gazaille
Claire Gazaille
Zeynep Güneş Tepe DemirZeynep Güneş Tepe Demir
Zeynep Güneş Tepe Demir
LGLéna Guyon
Léna Guyon
NLNolwenn Lautram
Nolwenn Lautram
GBGuillaume Bastiat
Guillaume Bastiat
Centrifugal filtration devices are increasingly being used to separate (bio)molecules thanks to their molar masses. This is partly due to their ease of use, with sample preparation requiring no complicated protocol and often being able to be run as is. Nevertheless, several limitations have been highlighted in the literature, such as proteins’ selectivity according to their molar masses, clogging problems and some post-separation quantification issues. We wanted to test the real potential of the centrifugal filtration devices as a characterization tool, by verifying their specificity using a library of peptides and proteins. The impact of the peptide charge on separation performance as well as the impact of biological material concentration and centrifugation rate were evaluated using three membranes with different cut-offs. A good specificity was confirmed: biological materials that have molar masses which are below the membrane cut-off can pass almost completely through the membrane, while those with molar masses above the membrane cut-off are almost fully retained. The findings proved more problematic when protein mixtures were analyzed: despite still having good specificity, biological materials with molar masses below the membrane cut-off only partially crossed the membranes, due to clogging effects, making quantification of the initial mixture incorrect. It is therefore essential to be very careful when working with centrifugal filtration devices, as their use requires precise and relevant controls, without necessarily being able to optimize the separation of mixtures. Thus, this remains far from an easy and ready-to-use system.